Kim, J.-H.; Nam, J.-K.; Park, M.-S.; Seo, S.; Ryu, H.C.; Lee, H.-J.; Lee, J.; Lee, Y.-J.
Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study. Int. J. Mol. Sci. 2025, 26, 7570.
https://doi.org/10.3390/ijms26157570
AMA Style
Kim J-H, Nam J-K, Park M-S, Seo S, Ryu HC, Lee H-J, Lee J, Lee Y-J.
Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study. International Journal of Molecular Sciences. 2025; 26(15):7570.
https://doi.org/10.3390/ijms26157570
Chicago/Turabian Style
Kim, Ji-Hee, Jae-Kyung Nam, Min-Sik Park, Seungyoul Seo, Hyung Chul Ryu, Hae-June Lee, Jeeyong Lee, and Yoon-Jin Lee.
2025. "Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study" International Journal of Molecular Sciences 26, no. 15: 7570.
https://doi.org/10.3390/ijms26157570
APA Style
Kim, J.-H., Nam, J.-K., Park, M.-S., Seo, S., Ryu, H. C., Lee, H.-J., Lee, J., & Lee, Y.-J.
(2025). Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study. International Journal of Molecular Sciences, 26(15), 7570.
https://doi.org/10.3390/ijms26157570
